Life‐Threatening Prolonged ICANS Following Tarlatamab Treatment in Extensive‐Stage Small Cell Lung Cancer With Brain Metastases: A Case Report
ABSTRACT We report the case of a 75‐year‐old woman with extensive‐stage small cell lung cancer (ES‐SCLC) who developed severe, prolonged immune effector cell‐associated neurotoxicity syndrome (ICANS) following tarlatamab. She had previously received first‐line carboplatin, etoposide, and durvalumab,...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wiley
2026-05-01
|
| Rangatū: | Respirology Case Reports |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1002/rcr2.70617 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|